Cyclin D1–CDK4/6 phosphorylates GTSE1 in cancer cells, preventing its degradation and sustaining high levels across the cell cycle, which enhances proliferation and correlates with poor prognosis.

Accurately counting viable cells in a sample is crucial for various biological assays, including normalization and assessing drug impacts on cell proliferation for cancer research. Regular cell ...

According to the case, European Data Protection Supervisor v. the EU Single Resolution Board, the SRB shared pseudonymized data with a contractor, Deloitte, but did not mention the company as a ...

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for identifying recurrence risks in patients with early-stage melanoma who do ...

Continuing, the ABUAD Chancellor said, “We cannot seriously speak of advancing sustainable development through high impact research unless we address this menace of the proliferation of ...

Biocartis announced the launch of its real-time quantitative polymerase chain reaction assay to detect POLE and POLD1 mutations in endometrial cancer. Biocartis has launched a fully automated, ...

One of the most familiar and widely used methods for quantifying cell proliferation is the measurement of tritiated ... N.J., offers both a [14C]-thymidine and a [3H]-thymidine uptake assay system, ...

The team, publishing in the journal Advanced Science, used a new drug discovery screening platform technology, called the Transcription Block Survival (TBS) assay, which tests a huge number of ...

The names of the investors were not disclosed. The Vancouver, Canada-based cancer testing firm said that it would use the funds to support the commercial launch of its lung cancer assay. This ...

Ninning Liu, a bioengineer at the Wyss Institute at Harvard University, elucidated the use of DNA barcodes in high-throughput assays to determine the expression of genes in a single cell. “The goal of ...